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Background: Inflammation is an important underlying mechanism in the pathogenesis of atherosclerosis, and an 
elevated resting heart rate underlies the process of atherosclerotic plaque formation. We hypothesized an associa-
tion between resting heart rate and subclinical inflammation.
Methods: Resting heart rate was recorded at baseline in the KoGES-ARIRANG (Korean Genome and Epidemiology 
Study on Atherosclerosis Risk of Rural Areas in the Korean General Population) cohort study, and was then divided 
into quartiles. Subclinical inflammation was measured by white blood cell count and high-sensitivity C-reactive 
protein. We used progressively adjusted regression models with terms for muscle mass, body fat proportion, and 
adiponectin in the fully adjusted models. We examined inflammatory markers as both continuous and categorical 
variables, using the clinical cut point of the highest quartile of white blood cell count (≥7,900/mm3) and ≥3 mg/dL 
for high-sensitivity C-reactive protein.
Results: Participants had a mean age of 56.3±8.1 years and a mean resting heart rate of 71.4±10.7 beats/min; 39.1% 
were men. In a fully adjusted model, an increased resting heart rate was significantly associated with a higher white 
blood cell count and higher levels of high-sensitivity C-reactive protein in both continuous (P for trend <0.001) and 
categorical (P for trend <0.001) models.
Conclusion: An increased resting heart rate is associated with a higher level of subclinical inflammation among 
healthy Korean people.
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introduCtion
Inflammation is an important underlying mechanism in the patho-
genesis of atherosclerosis.1,2) Subclinical inflammation and levels of 
various inflammatory markers correlate strongly with cardiovascular 
morbidity and mortality in both healthy individuals and those with 
known coronary artery disease (CAD).3,4) The levels of various inflam-
matory markers, including white blood cell (WBC) count and levels of 
high-sensitivity C-reactive protein (hs-CRP), have proved to be inde-
pendently associated with atherosclerosis, as represented by the angi-
ographic confirmation of CAD.5-7)
 Epidemiological evidence indicates that an elevated resting heart 
rate (HR) is an independent marker of both all-cause and cardiovascu-
lar-specific mortality.8-12) An elevated resting HR is also associated with 
endothelial dysfunction,13) severity of CAD,14,15) and eventually plaque 
rupture,16) indicating that an elevated HR underlies every process of 
atherosclerotic plaque formation.
 Previous epidemiologic studies have demonstrated that HR is asso-
ciated with inflammatory biomarkers, but those studies were limited 
either by missing covariates, such as body composition and adiponec-
tin, or by the inclusion of participants with cardiovascular disease.17-20) 
Thus, we hypothesized that an elevated resting HR is associated with 
inflammation, as measured by 2 different markers (WBC count and 
hs-CRP), and we evaluated this hypothesis by using multivariate ad-
justed analysis in healthy Korean people without apparent cardiovas-
cular disease.
Methods
1. study Population
We used data from the baseline visit (2005–2007) of the Korean Ge-
nome and Epidemiology Study on Atherosclerosis Risk of Rural Areas 
in the Korean General Population (KoGES-ARIRANG), a population-
based prospective cohort study designed to assess the prevalence, in-
cidence, and risk factors for chronic degenerative disorders, such as 
hypertension, diabetes, osteoporosis, and cardiovascular disease. The 
baseline examinations were carried out in the rural areas of Wonju 
and Pyeongchang from November 2005 to January 2008.
 Of the 10,107 adults who comprised the KoGES-ARIRANG cohort, 
we excluded 2506 individuals because of a missing resting HR value, 
WBC count, or hs-CRP value (n=351); a history of cerebrovascular dis-
ease (n=204) or heart disease (n=313); or other missing data (n=706). 
To eliminate individuals with acute phase inflammation, we excluded 
individuals with a clinically abnormal WBC count (more than 10,000/
mm3; n=757) or an hs-CRP level ≥10 mg/L (n=175). Finally, 7,601 par-
ticipants (2,975 men, 4,626 women) were analyzed.
2. data Collection
At baseline and follow-up examinations, study subjects completed a 
standardized medical history and lifestyle questionnaire and under-
went a comprehensive health examination according to standard pro-
cedures. Body weight and height were measured while subjects wore 
light indoor clothing without shoes. Waist circumference was mea-
sured in a horizontal plane, midway between the inferior margin of 
the ribs and the superior border of the iliac crest, using a tape measure 
(SECA-200; SECA, Hamburg, Germany). Muscle mass and body fat 
proportion were measured by bioelectrical impedance analysis (Zeus 
9.9; Jawon Medical Co. Ltd., Kyoungsan, Korea). Participants’ resting 
HR was recorded during the baseline examination, using an automatic 
blood pressure monitor (FT-500, Jawon Medical Co. Ltd.). The auto-
matic blood pressure monitor measured the frequency of the heart-
beat and time duration while measuring the blood pressure, and the 
heartbeats per minute were calculated. Systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) were measured twice in the right 
arm by using a standard mercury sphygmomanometer (Baumanome-
ter, Copiague, NY, USA). The mean of the 2 blood pressure readings 
was used for data analyses. Smoking status was determined based on 
self-report. Nonsmokers were defined as subjects who had smoked 
<100 cigarettes (<5 packs of cigarettes) in their lifetime. Current smok-
ers were defined as subjects who had smoked ≥100 cigarettes in their 
lifetime and who reported that they were ‘currently smoking’ in the 
questionnaire. Former smokers were defined as subjects who had 
smoked ≥100 cigarettes in their lifetime but who reported that they 
‘abstain from smoking’ in the questionnaire.
 A venous blood sample was drawn from study participants after a 
12-hour or overnight fast. Serum concentrations of adiponectin were 
measured by radioimmunoassay (LINCO Research Inc., St. Charles, 
MO, USA), with intra-assay coefficients of variation ranging between 
2.9% and 6.6%. Fasting glucose was determined by a glucose-oxidase 
based assay. Serum concentrations of low-density lipoprotein (LDL) 
cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycer-
ides were determined by enzymatic methods (Avida 1650, Siemens, 
Tarrytown, NY, USA). WBC count was measured using an automated 
blood cell counter (ADVIA 120, Bayer, NY, USA). hs-CRP was mea-
sured by the Denka Seiken (Tokyo, Japan) assay, which has been vali-
dated against the Dade Behring method.
 Hypertension was defined as SBP ≥140 mm Hg or DBP ≥90 mm Hg, 
or a self-report of hypertension, or the use of an antihypertensive 
medication; diabetes mellitus was defined as a fasting plasma glucose 
level ≥126 mg/dL, or glycated hemoglobin (HbA1c) ≥6.5%, or clinically 
known and treated diabetes mellitus.
3. statistical Analyses
Participants were divided into resting HR quartiles (Q1: n=2,039, Q2: 
n=1,817, Q3: n=2,020, Q4: n=1,725). Baseline characteristics for the 
continuous variables were expressed as means±standard deviations, 
and comparisons between groups were performed using a 1-factor 
analysis of variance. Categorical data are summarized as percentages, 
and comparisons between groups were performed using the Pearson 
chi-square test.
 Inflammation was examined as a continuous variable using linear 
regression models. hs-CRP was not normally distributed and was 
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therefore log transformed for continuous analyses. In categorical anal-
yses of the inflammatory variables, we used the clinical cut point for a 
normal hs-CRP <3 mg/dL as the reference group and an elevated hs-
CRP ≥3 mg/dL as the subclinical inflammation group. To set the cut 
point of WBC count, the study population was divided into WBC count 
quartiles. We set the highest quartile of WBC count (≥7,900/mm3) as 
the subclinical inflammation group, with the three lowest WBC count 
quartiles as the reference group.
 For each of our secondary analyses, we used these categorical cut 
points to calculate the odds ratio (OR) and 95% confidence interval 
(CI). The results of these analyses are interpreted as the OR of having 
an elevated inflammatory level compared with a non-elevated level for 
each HR quartile, with the lowest HR quartile as the reference. To eval-
uate the adjusted OR, we ran 3 multivariate logistic regression models. 
Model I included age and sex. Model 2 added smoking status, SBP, 
DBP, fasting plasma glucose, HbA1c, LDL and HDL cholesterol, tri-
glycerides, body mass index, waist circumference, hypertension, dia-
betes mellitus, and lipid-lowering medication use. Model 3 added 
muscle mass, body fat proportion, and serum adiponectin level.
 The level of significance used for all of the above analyses was a 
Table 1. Participant characteristics by baseline resting heart rate quartile
Characteristic
Baseline resting heart rate quartile
P for trend
1 2 3 4
Resting heart rate (beats/min) 59.4 (36, 64) 67.6 (65, 70) 74.3 (71, 78) 86.4 (79, 129) <0.001
Age (y) 56.9±7.8 56.2±8.1 55.5±8.2 56.5±8.4 0.016
Men (%) 48.2 36.0 35.2 36.3 <0.001
Current smoker (%) 14.6 13.8 14.7 17.0 0.039
Systolic blood pressure (mm Hg) 129.8±18 130.1±18 130.1±18 132.6±19 <0.001
Diastolic blood pressure (mm Hg) 81.1±11 82.1±11 82.5±11 85.0±12 <0.001
Fasting plasma glucose (mg/dL) 94.0±20 94.6±19 96.6±23 101.5±33 <0.001
Glycated hemoglobin (%) 5.6±0.8 5.6±0.8 5.6±0.8 5.8±1.0 <0.001
Low-density lipoprotein (mg/dL) 118.0±32 119.6±32 120.1±33 119.6±35 0.119
High-density lipoprotein (mg/dL) 46.2±11 46.4±11 46.3±11 46.2±11 0.889
Triglycerides (mg/dL) 120 (82–177) 124 (87–177) 126 (88–187) 140 (96–205) <0.001
Body mass index (kg/m2) 24.4±3.0 24.4±3.0 24.4±3.2 24.3±3.4 0.806
Waist circumference (cm) 83.4±8.2 83.0±8.5 82.9±8.7 83.8±8.7 0.275
Hypertension (%) 39.8 39.8 40.4 45.4 0.001
Diabetes mellitus (%) 11.9 11.5 12.7 17.1 <0.001
Lipid-lowering medication (%) 2.1 1.9 1.7 1.0 0.017
Muscle mass (kg) 41.2±7.5 40.0±7.1 39.8±7.2 39.5±7.3 <0.001
Body fat proportion (%) 28.0±6.8 29.0±6.2 29.2±6.5 29.0±6.9 <0.001
Adiponectin (μg/mL) 9.60 (6.58–13.33) 9.68 (6.50–13.35) 9.46 (6.25–13.16) 9.22 (6.35–12.94) 0.026
White blood cell (cells/mm3) 6,540±1,500 6,600±1,540 6,700±1,500 6,970±1,520 <0.001
High-sensitivity C-reactive protein (mg/dL) 0.73 (0.39–1.47) 0.72 (0.37–1.44) 0.78 (0.41–1.63) 0.84 (0.44–1.80) <0.001
Values are presented as mean (minimum, maximum), mean±standard deviation, %, or median (interquartile range), unless otherwise indicated.
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Figure 1. Percentage of participants in the upper quartile (A) of white blood cell (≥7,900/mm3) or (B) with an high sensitivity C-reactive protein ≥3.0 mg/dL by resting heart 
rate quartile.
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2-tailed P-value <0.05. All calculations were performed using PASW 
SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA).
results
At baseline examination, participants with a higher resting HR were 
more likely to be women, and more likely to have hypertension or dia-
betes mellitus, higher blood pressure, higher levels of fasting plasma 
glucose, HbA1c, and triglycerides, and a greater body fat proportion 
(Table 1). Mean values of WBC count and hs-CRP level were higher 
among those with higher resting HR. Participants with a lower resting 
HR were more likely to be men, to have more muscle mass, to be taking 
a lipid-lowering medication, and to have a higher adiponectin level.
 For both inflammatory markers, an increase in resting HR was asso-
ciated with an increased percentage of subjects who had an elevated 
inflammatory level. The absolute percentage of subjects classified with 
an elevated inflammatory level was higher for WBC count (29.2% in 
quartile 4) (Figure 1A) than for hs-CRP (13.7% in quartile 4) (Figure 
1B).
 In linear regression models, WBC count increased with increasing 
HR after multivariate adjustment (P for trend <0.001) (Table 2), and it is 
notable that the increment in the b coefficient was much larger in the 
fourth quartile than in other quartiles. Although the difference in b co-
efficient between the second and reference quartiles was not statisti-
cally significant, hs-CRP also showed a tendency to increase with in-
creasing HR after multivariate adjustment (P for trend <0.001) (Table 2).
 Participants with a higher resting HR also had a progressively in-
creased risk of having an elevated inflammatory marker compared 
with those with a lower resting HR (P for trend <0.001 for both mark-
ers) (Table 3). In the fully adjusted model, the OR for being in the up-
per quartile of WBC count (≥7,900/mm3) was significantly increased 
for all resting HR quartiles. The OR for having an hs-CRP level ≥3 mg/
dL was also increased for all resting HR quartiles, but it was only statis-
tically significant for the fourth quartile compared to the first. For the 
highest quartile of resting HR, the OR for having an elevated inflam-
matory marker was similar across the 2 inflammatory markers (OR, 
1.527; 95% CI, 1.303 to 1.789 for WBC; OR, 1.555; 95% CI, 1.258 to 1.923 
for hs-CRP). The association between resting HR and both inflamma-
tory markers showed amplification, which means that the increment 
in the OR was much larger in the fourth quartile compared with other 
quartiles.
disCussion
A number of epidemiologic studies have demonstrated that resting HR 
is associated with inflammatory biomarkers. Rogowski et al.17) report-
ed that resting HR was significantly associated with a micro-inflamma-
tory response (fibrinogen, hs-CRP, and polymorphonuclear leukocyte 
Table 2. Estimated increase in WBC counts and levels of hs-CRP, stratified by 
baseline resting heart rate quartile
Marker
Resting heart rate quartile, b coefficient
P for trend
1 2 3 4
WBC (cells/mm3)
   Unadjusted Reference 0.017 0.048* 0.117* <0.001
   Model 1 Reference 0.037* 0.070* 0.135* <0.001
   Model 2 Reference 0.030* 0.056* 0.109* <0.001
   Model 3 Reference 0.030* 0.053* 0.105* <0.001
hs-CRP (mg/L)†
   Unadjusted Reference -0.009 0.022 0.061* <0.001
   Model 1 Reference 0.009 0.048* 0.075* <0.001
   Model 2 Reference 0.004 0.037* 0.053* <0.001
   Model 3 Reference 0.005 0.035* 0.051* <0.001
Model 1: age and sex; model 2: model 1+smoking, systolic blood pressure, diastolic 
blood pressure, fasting plasma glucose, glycated hemoglobin, low-density lipoprotein 
cholesterol, high-density lipoprotein cholesterol, triglycerides, body mass index, waist 
circumference, hypertension, diabetes mellitus, and lipid-lowering medication; model 
3: model 2+muscle mass, body fat proportion, and serum adiponectin level.
WBC, white blood cell; hs-CRP, high-sensitivity C-reactive protein.
*P<0.05. †Presented using log-transformed values.
Table 3. ORs and 95% CIs for being in the upper quartile of WBC counts (≥7,900/mm3) or having a hs-CRP level ≥3 mg/dL
Marker
Resting heart rate quartile
P for trend
1 2 3 4
WBC (cells/mm3)
   Unadjusted Reference 1.135 (0.974–1.322) 1.233 (1.064–1.429)* 1.568 (1.351–1.820)* <0.001
   Model 1 Reference 1.223 (1.047–1.427)* 1.342 (1.155–1.558)* 1.691 (1.454–1.967)* <0.001
   Model 2 Reference 1.196 (1.022–1.400)* 1.283 (1.101–1.495)* 1.561 (1.333–1.827)* <0.001
   Model 3 Reference 1.198 (1.023–1.403)* 1.270 (1.089–1.480)* 1.527 (1.303–1.789)* <0.001
hs–CRP (mg/L)
   Unadjusted Reference 1.026 (0.828–1.272) 1.116 (0.908–1.370) 1.523 (1.245–1.864)* <0.001
   Model 1 Reference 1.084 (0.873–1.346) 1.205 (0.979–1.483) 1.596 (1.302–1.957)* <0.001
   Model 2 Reference 1.082 (0.869–1.346) 1.198 (0.970–1.478) 1.564 (1.266–1.933)* <0.001
   Model 3 Reference 1.087 (0.873–1.354) 1.192 (0.965–1.473) 1.555 (1.258–1.923)* <0.001
Values are presented as OR (95% CI). Model 1: age and sex; model 2: model 1+smoking status, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, 
HbA1c, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, body mass index, waist circumference, hypertension, diabetes mellitus, and lipid-
lowering medication; model 3: model 2+muscle mass, body fat proportion, and serum adiponectin level.
OR, odds ratio; CI, confidence interval; WBC, white blood cell; hs-CRP, high-sensitivity C-reactive protein.
*P<0.05.
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count) in a cohort of 4,553 healthy men and in those with athero-
thrombotic risk factors. In the Okinawa General Health Maintenance 
Association cohort of 8,772 participants, there was an independent re-
lationship between elevated resting HR and WBC count in middle-
aged and elderly healthy Japanese individuals.18) Ó Hartaigh et al.19) 
found that elevated inflammatory biomarkers (interleukin-6, hs-CRP, 
serum amyloid A, neutrophils, and fibrinogen) were associated with 
cardiovascular mortality and that the effects of inflammation appeared 
to be strongly amplified by an increased resting HR. Moreover, Whel-
ton et al.20) reported that an increased resting HR was associated with 
higher levels of inflammatory biomarkers (hs-CRP, interleukin-6, and 
fibrinogen) among an ethnically diverse group of subjects without 
known cardiovascular disease.
 The present study assessed the interrelationship between resting 
HR and subclinical inflammation. Our findings indicated that resting 
HR was significantly associated with increased levels of inflammation, 
as measured by 2 different inflammatory biomarkers. Consistently 
with previous studies, we found that an increased resting HR was as-
sociated with adverse cardiovascular risk factors, including an increase 
in blood pressure, triglycerides, diabetes, and body fat proportion. 
However, our results show that the association of HR with inflamma-
tion was independent of these risk factors.
 Compared with individuals in the first quartile of resting HR, which 
was the reference group of this study, the OR for the fourth quartile 
was approximately 1.5 for both WBC count and hs-CRP. Thus, individ-
uals with a resting HR of more than 79 beats per minute had a higher 
risk of subclinical inflammation, and hence of the subsequent devel-
opment of atherosclerosis and future cardiovascular events. Our re-
sults are compatible with previous epidemiological evidence that a 
resting HR of more than 75 beats per minute is hazardous for cardio-
vascular mortality.19)
 There are 2 potential mechanisms that link elevated resting HR and 
subclinical inflammation: sympathetic overactivation and mechanical 
stress. The autonomic nervous system plays a role in immune system 
regulation and the inflammatory response. Tumor necrosis factor 
(TNF) is an inflammatory cytokine that precipitates vascular damage 
through capillary leakage and microvascular thrombosis.21) Vagal 
nerve stimulation attenuates inflammation by downregulating the re-
lease of TNF and other cytokines from macrophages.22,23)
 Another mechanism that links elevated resting HR with subclinical 
inflammation might be mechanical stress on vascular endothelium.24) 
There are 2 types of mechanical stress. One is shear stress, a frictional 
force on the arterial wall, and the other is tensile stress, a radial force 
that stretches the arterial wall. Elevated HR increases the frequency of 
oscillatory shear stress to the vascular endothelium,25) which promotes 
endothelial superoxide anion expression26) and vascular cell adhesion 
molecule expression, thus enhancing endothelial monocyte adhe-
sion.27-29)
 One of the strengths of our study is that it is the first large cross-sec-
tional study in Korea to highlight the relationship between resting HR 
and inflammatory markers in a healthy general population. Moreover, 
we evaluated our hypothesis by multivariate adjustment, including 
important covariates such as body composition and adiponectin, 
which to our knowledge has not been reported by previous analyses.
 The present study is not without limitations. Its cross-sectional na-
ture does not provide information with regard to temporality. Al-
though the study was prospective as regards patient enrolment, resting 
HR was only estimated at a single time point and therefore may not re-
flect the HR over a longer period. Furthermore, HR shows significant 
diurnal variation but HR was not always measured at the same time of 
the day in this study. Similarly, the single measurement of inflamma-
tory markers may not accurately reflect the long-term inflammatory 
state of an individual participant. Lastly, we did not take into consider-
ation the effect of medicines, such as b-blockers and non-dihydropyri-
dine calcium channel blockers, on resting HR.
 In conclusion, the present study provides evidence that an elevated 
resting HR was independently associated with increased inflammatory 
markers in healthy Korean people. Our finding demonstrates the clini-
cal significance of resting HR for identifying individuals at risk of sub-
clinical inflammation and a future cardiovascular event.
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